Investigating Serious and Fatal Bleeding Events Caused by Xarelto
Colling Gilbert Wright & Carter are now accepting product liability claims involving Xarelto, a blood thinner approved for use in 2011 and manufactured by Bayer pharmaceuticals. Although only on the market for a few years, Xarelto has been associated with serious, sometimes fatal, internal bleeding and brain hemorrhaging. Much like the blood thinner Pradaxa, which settled thousands of lawsuits in 2013, there is no known antidote for bleeding caused by Xarelto. The failure to warn of this potentially fatal shortcoming of the drug will be central to the lawsuits of those injured, or the families of those who have died, as a result of Xarelt-related bleeding events.
If yourself or a loved one have had serious or fatal bleeding events such as intestinal or brain hemorrhaging, please contact Colling Gilbert Wright & Carter for a fee evaluation of your potential legal claims.